Company Profile

Industry:Pharmaceuticals

Site:adispell.com

Description:ADispell is a R&D company developing central nervous system therapeutics based on technology licensed from Cornell University. The company has identified lead compounds, has performed in vivo experiments with extremely successful results, and is now moving quickly to complete pre-clinical work. The company is developing drug products that could be used for Alzheimer's disease, schizophrenia, Parkinson's, and other diseases that may cause memory loss.
The company has found that some of its...

Specialties:pharmaceutical development, R&D

Founded:2010

Company size:1-10 employees